Pharmaceuticals, Biotechnology and Life Sciences
Phase 1 clinical trial, expected to start in H2 2019, will be co-funded by Transgene and its collaboration partner NEC…
Microphyt secures one of the largest fundraising in the microalgae sector; The round was co-led by Sofinnova Partners and Bpifrance…
Gerresheimer AG has had a successful second quarter, en route to meeting all of its targets for 2019, Dietmar Siemssen, the CEO, has said in a press release Tursday.
Ireland becomes the 13th country with Tilray medical cannabis products as company continues global expansion in Europe and increases access to patients in need
SELBYVILLE, Del.–(BUSINESS WIRE)–#Ambulatorysurgicalcenters–The inhalation anesthesia market from maintenance segment accounted for more than 80% revenue share in 2018 and will…
NEW YORK–(BUSINESS WIRE)–#MDSO—Medidata (NASDAQ: MDSO) today announced that it will release its second quarter 2019 results after the close of…
Nexus Pharmaceuticals will invest $250 million to build U.S. based pharmaceutical facility bringing hundreds of new high-tech manufacturing jobs to…
Record quarter as revenues grow 16%, 9MoFY19 revenues up 13% Board of Directors announces quarterly dividend of $0.06 per share…
Strong patent rights are essential to finance the revolution in biotechnology discoveries from the lab to the patient, farmer, and…
DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a quarterly dividend…